Pharma magazine talks about SAFC’s HPAPI expansion plans….

Corrine Lawrence, Editor of Pharma magazine, recently spoke with SAFC about the company’s aggressive expansion program that is bolstering manufacturing capabilities in the high potency API space.  The recent addition of a cGMP-validated extension to SAFC’s Madison, Wisconsin plant is just the latest in a series of investments made by the company in high potency manufacturing in the past couple of years.  Reflecting the demand being seen from customers, who require ever-growing amounts of high potency compounds in order to manufacture the growing number of high-efficacy, targeted therapeutics being brought to market, SAFC has a program of ‘centers of excellence’ and is investing to match the needs of customers.

You can read the full Pharma article here

Bookmark and Share

Leave a Reply